• Prochlorperazine: Deep Mechanistic Insights for Oncology and

  2026-04-28

  Explore Prochlorperazine’s multifaceted role as a dopamine D2 receptor antagonist in oncology and antiviral research. This article offers advanced mechanistic analysis, practical protocol guidance, and unique cross-domain insights not found in prior reviews.

• Demethyleneberberine Inhibits NF-κB/MAPK in Autoimmune Hepat

  2026-04-28

  This study demonstrates that Demethyleneberberine (DMB), a natural isoquinoline alkaloid, attenuates concanavalin A-induced autoimmune hepatitis in mice by suppressing NF-κB and MAPK signaling pathways. The findings highlight DMB's potential as a multi-pathway anti-inflammatory compound with translational relevance for autoimmune and inflammatory liver research.

• Sulfamonomethoxine: Protocols, Environmental Impact & Innova

  2026-04-27

  Sulfamonomethoxine (SMM) is redefining standards in veterinary, aquaculture, and environmental research with its robust antibacterial action and unique biotransformation routes. This article delivers actionable protocols, troubleshooting insights, and the latest findings on SMM’s fate and safety, empowering researchers to balance efficacy and stewardship.

• EGTA in Translational Research: Precision in Calcium Modulat

  2026-04-27

  This article explores EGTA (egtaizic acid) as a selective calcium chelator, bridging mechanistic insights with actionable strategies for translational researchers. Unpacking the latest neurophysiological evidence and competitive perspectives, it guides the rational deployment of EGTA in neurodegenerative disease models, apoptosis assays, and vascular inflammation studies—integrating protocol parameters, cross-domain considerations, and a visionary outlook for the next decade of calcium signaling research.

• EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

  2026-04-26

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent for efficient amide bond formation in peptide synthesis, bioconjugation, and nucleotide coupling workflows. It is strictly recommended for in vitro applications and should not be used in in vivo or clinical research due to the lack of supporting data.

• TRIM21 Promotes ERK1/2-Driven Proliferation and Resistance i

  2026-04-25

  This study uncovers TRIM21 as a key oncogenic driver in pituitary adenomas, facilitating cell proliferation and resistance to dopamine agonists by modulating ERK1/2 ubiquitination and phosphorylation. The identification of Quisinostat as an effective agent for downregulating TRIM21 expression presents a potential therapeutic avenue for drug-resistant pituitary tumors.

• Berberrubine Chloride: Advanced Workflows for Cancer & Metab

  2026-04-24

  Berberrubine chloride (9-hydroxy-10-methoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium chloride) unlocks multiplexed bioactivity for translational cancer and metabolic research. This guide details experimental workflows, optimization tactics, and troubleshooting tips to maximize the impact of this selective, DMSO-soluble alkaloid.

• Dimethyloxalylglycine (DMOG): Technical Use and Protocol Gui

  2026-04-24

  Dimethyloxalylglycine (DMOG) provides a controlled, reproducible method for stabilizing hypoxia-inducible factors in cell and animal models—supporting hypoxia, inflammation, and infection research. It is not appropriate for diagnostic or clinical applications and should be used strictly according to laboratory protocols.

• Baicalein (5,6,7-Trihydroxy-2-phenylchromen-4-one): Mechanis

  2026-04-23

  Baicalein is a flavonoid compound known for potent inhibition of arachidonic acid metabolism and anti-proliferative effects on cancer cells. It is widely utilized in apoptosis and inflammation pathway research, with high solubility in DMSO and ethanol. Strict storage (-20°C) and handling protocols ensure optimal stability for laboratory applications.

• Prochlorperazine (SKU A8508): Reliable Research Applications

  2026-04-23

  This article provides scenario-driven guidance for biomedical researchers utilizing Prochlorperazine (SKU A8508) in cell viability, cytotoxicity, and melanoma studies. Evidence-based protocol parameters, real-world troubleshooting, and vendor selection considerations are explored, supporting reproducible outcomes in cancer and antiviral research workflows.

• Hydroxytyrosol: Precision Redox Modulation in Cardiovascular

  2026-04-22

  Explore the advanced redox-modulating properties of Hydroxytyrosol, a phenolic compound central to cardiovascular health research. This article delivers a unique, mechanistic perspective and practical assay guidance, distinguishing it from standard protocol or workflow content.

• U0126-EtOH: Mechanistic Precision for Translational Impact

  2026-04-22

  Explore how the MEK1/2 inhibitor U0126-EtOH empowers translational researchers to dissect and modulate the MAPK/ERK pathway in models of neuroprotection and inflammation. This thought-leadership article bridges mechanistic insight with strategic guidance, drawing on cutting-edge literature—including the role of MAPK signaling in nonapoptotic cell death—to drive bench-to-bedside innovation. Protocol recommendations, evidence-labeled claims, and comparative analysis position APExBIO’s U0126-EtOH as a cornerstone reagent for advanced oxidative stress and immune research.

• Liproxstatin-1: Precision Ferroptosis Inhibitor for Advanced

  2026-04-21

  Liproxstatin-1 empowers researchers to dissect ferroptosis mechanisms with nanomolar precision, enabling robust inhibition of lipid peroxidation in disease models from renal injury to glandular dysfunction. This guide translates the latest experimental insights and troubleshooting strategies into actionable protocols for maximizing Liproxstatin-1’s impact in applied ferroptosis research.

• Triptolide (PG490): Precision Disruption of Transcriptional

  2026-04-21

  This thought-leadership article explores how Triptolide (PG490) redefines transcriptional targeting in cancer and immune modulation. We bridge fundamental mechanistic insights—including the direct inhibition of RNAPII and regulatory cytokines—with strategic guidance for translational researchers. Key evidence from recent literature and protocol recommendations are integrated, with explicit attention to workflow design and experimental rigor. The article escalates the current discourse beyond technical product descriptions, offering a forward-looking vision on leveraging Triptolide for next-generation disease models.

• Phebestin as a Novel Aminopeptidase Inhibitor for Malaria Co

  2026-04-20

  This study systematically evaluates phebestin, a bestatin-related aminopeptidase inhibitor, for its antiplasmodial activity against both chloroquine-sensitive and -resistant Plasmodium falciparum strains. The findings highlight phebestin’s nanomolar efficacy, low cytotoxicity, and distinct mode of action, positioning it as a promising lead for future antimalarial drug development.

15384 records 1/1026 page Next 12345 下5页 Last page